Influence of Drug Transport Proteins on the Pharmacokinetics and Drug Interactions of Hiv Protease Inhibitors-Reference-Cited by-同舟云学术

Influence of Drug Transport Proteins on the Pharmacokinetics and Drug Interactions of Hiv Protease Inhibitors

Published:2011-09 Issue:9 Volume:100 Page:3636-3654
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Griffin Latoya,Annaert Pieter,Brouwer Kim L.R.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference170 articles.

1. Saquinavir: An HIV protease inhibitor;Bragman;Adv Exp Med Biol,1996

2. Anonymous. 2011. Antiretroviral drugs used in the treatment of HIV infection. http://www.fda.gov/ForConsumers/byAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm118915.htm. Last Accessed May 10, 2011.

3. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel;Thompson;JAMA,2010

4. HIV monotherapy with ritonavir-boosted protease inhibitors: A systematic review;Bierman;AIDS,2009

5. Darunavir: A second-generation protease inhibitor;Busse;Am J Health Syst Pharm,2007

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using a Graph Convolutional Neural Network Model to Identify Bile Salt Export Pump Inhibitors;ACS Omega;2023-06-06

2. Knockout of ABC transporters by CRISPR/Cas9 contributes to reliable and accurate transporter substrate identification for drug discovery;Frontiers in Pharmacology;2022-10-28

3. Hybrid QM/MM Free-Energy Evaluation of Drug-Resistant Mutational Effect on the Binding of an Inhibitor Indinavir to HIV-1 Protease;Journal of Chemical Information and Modeling;2022-02-25

4. Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients;Expert Review of Clinical Pharmacology;2021-11-26

5. Herbal Drug Interaction: Mechanistic Details through Pharmacokinetic Portfolio;CNS & Neurological Disorders - Drug Targets;2021-10